1. A Randomized, Double‐Blind, Placebo‐ and Positive‐Controlled, Three‐Way Crossover Study in Healthy Participants to Investigate the Effect of Savolitinib on the QTc Interval. Issue 5 (5th January 2021) Authors: Sahota, Tarjinder; Dota, Corina D.; Vik, Torbjörn; Yan, Weili; Verheijen, Remy B.; Walker, Stephen; Li, Yan; Goldwater, Ronald; Ghiorghiu, Dana; Mellemgaard, Anders; Ahmed, Ghada F. Journal: Clinical pharmacology in drug development Issue: Volume 10:Issue 5(2021) Page Start: 521 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Analysis of patient-reported outcomes from the LUME-Lung 1 trial: A randomised, double-blind, placebo-controlled, Phase III study of second-line nintedanib in patients with advanced non-small cell lung cancer. Issue 3 (February 2015) Authors: Novello, Silvia; Kaiser, Rolf; Mellemgaard, Anders; Douillard, Jean-Yves; Orlov, Sergey; Krzakowski, Maciej; von Pawel, Joachim; Gottfried, Maya; Bondarenko, Igor; Liao, Meilin; Barrueco, José; Gaschler-Markefski, Birgit; Griebsch, Ingolf; Palmer, Michael; Reck, Martin; LUME-Lung 1 Study Group Journal: European journal of cancer Issue: Volume 51:Issue 3(2015:Feb.) Page Start: 317 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Anti-angiogenic-specific adverse events in patients with non-small cell lung cancer treated with nintedanib and docetaxel. Issue 2 (November 2015) Authors: Reck, Martin; Mellemgaard, Anders; von Pawel, Joachim; Gottfried, Maya; Bondarenko, Igor; Cheng, Ying; Zarogoulidis, Kostas; Luft, Alexander; Bennouna, Jaafar; Barrueco, José; Aboshady, Hesham; Hocke, Julia; Kaiser, Rolf; Douillard, Jean-Yves Journal: Lung cancer Issue: Volume 90:Issue 2(2015:Nov.) Page Start: 267 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Assessing the pattern of recurrence in Danish stage I lung cancer patients in relation to the follow-up program: are we failing to identify patients with cerebral recurrence?. (2nd November 2018) Authors: Christensen, Niels Lyhne; Dalton, Susanne Oksbjerg; Mellemgaard, Anders; Christensen, Jane; Kejs, Anne Mette Tranberg; Rasmussen, Torben Riis Journal: Acta oncologica Issue: Volume 57:Number 11(2018) Page Start: 1556 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Geographical variations in the use of cancer treatments are associated with survival of lung cancer patients. Issue 6 (6th March 2018) Authors: Møller, Henrik; Coupland, Victoria H; Tataru, Daniela; Peake, Michael D; Mellemgaard, Anders; Round, Thomas; Baldwin, David R; Callister, Matthew E J; Jakobsen, Erik; Vedsted, Peter; Sullivan, Richard; Spicer, James Journal: Thorax Issue: Volume 73:Issue 6(2018) Page Start: 530 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Impact of MET status on treatment outcomes in papillary renal cell carcinoma: A pooled analysis of historical data. (July 2022) Authors: Albiges, Laurence; Heng, Daniel Y.C.; Lee, Jae Lyun; Walker, Stephen; Mellemgaard, Anders; Ottesen, Lone; Frigault, Melanie M.; L'Hernault, Anne; Wessen, Jonathan; Choueiri, Toni; Cancel, Mathilde; Signoretti, Sabina Journal: European journal of cancer Issue: Volume 170(2022) Page Start: 158 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Intracranial effect of osimertinib in relapsed EGFR-mutated T790M-positive and -negative non-small cell lung cancer patients: results from a phase II study. (2nd December 2021) Authors: Eide, Inger Johanne Zwicky; Grut, Harald; Helland, Åslaug; Ekman, Simon; Sørensen, Jens Benn; Hansen, Karin Holmskov; Grønberg, Bjørn Henning; Cicenas, Saulius; Koivunen, Jussi Pekka; Mellemgaard, Anders; Brustugun, Odd Terje Journal: Acta oncologica Issue: Volume 60:Number 12(2021) Page Start: 1565 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Long-lasting disease stabilization in the absence of toxicity in metastatic lung cancer patients vaccinated with an HLA-A2-restricted epitope derived from indoleamine 2, 3 dioxygenase. (7th November 2013) Authors: Iversen, Trine Z; Engell-Noerregaard, Lotte; Ellebaek, Eva; Andersen, Rikke; Larsen, Stine K; Bjoern, Jon; Zeyher, Claus; Gouttefangeas, Cécile; Thomsen, Birte M; Holm, Bente; Straten, Per thor; Mellemgaard, Anders; Andersen, Mads H; Svane, Inge M Journal: Journal for immunotherapy of cancer Issue: Volume 1(2013)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Monte Carlo calculations support organ sparing in Deep-Inspiration Breath-Hold intensity-modulated radiotherapy for locally advanced lung cancer. Issue 1 (October 2015) Authors: Ottosson, Wiviann; Sibolt, Patrik; Larsen, Christina; Lykkegaard Andersen, Jon A.; Borissova, Svetlana; Mellemgaard, Anders; Behrens, Claus F. Journal: Radiotherapy and oncology Issue: Volume 117:Issue 1(2015:Oct.) Page Start: 55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Monte Carlo calculations support organ sparing in Deep-Inspiration Breath-Hold intensity-modulated radiotherapy for locally advanced lung cancer. Issue 1 (October 2015) Authors: Ottosson, Wiviann; Sibolt, Patrik; Larsen, Christina; Lykkegaard Andersen, Jon A.; Borissova, Svetlana; Mellemgaard, Anders; Behrens, Claus F. Journal: Radiotherapy and oncology Issue: Volume 117:Issue 1(2015:Oct.) Page Start: 55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗